SCHEMBL973458

SCHEMBL973458

OC1CCCN(c2nccs2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.47
HRH3 Q9Y5N1 2/20 0.46
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.41
GRM5 P41594 1/20 0.41
GRM1 Q13255 1/20 0.41
PIM1 P11309 1/20 0.41
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KCNMA1 Q12791 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4C Q9H3R0 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
POLB P06746 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525971 0.90 HPGD (0.49) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL4525966 0.90 HPGD (0.49) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL2037378 0.87 HPGD (0.53) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL2640732 0.83 KDM4C (0.44) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL975076 0.81 PBK (0.44) HPGDHSD17B10MEN1GRM5GRM1
SCHEMBL2036931 0.80 HPGD (0.55) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL7234810 0.79 KDM4C (0.53) HPGDHRH3HSD17B10MEN1GRM5
SCHEMBL972304 0.78 HPGD (0.51) HPGDHTTROCK2ROCK1CDC42BPB
SCHEMBL15058848 0.77
SCHEMBL160290 0.77 NPC1 (0.53) HPGDHRH3HSD17B10MEN1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871999-B2 Substituted thiazoles and their use for producing drugs GRUENENTHAL GMBH (DE) 2011-01-18 US disclosed
EP-1968957-B1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2010-01-20 EP disclosed
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-07-09 US disclosed
WO-2007079960-A9 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2008-10-23 WO disclosed
EP-1968957-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079960-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS TPMT, SLC5A2, DPP4 HPGD 724/4885HRH3 2654/4885HSD17B10 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.